All Posts By

Smartkarma Daily Briefs

Daily Brief Consumer: JD.com , Seven & I Holdings, Macy’s Inc, Signet Jewelers, Target Corp, Abercrombie & Fitch Co Cl A, TSE Tokyo Price Index TOPIX, Arcos Dorados Holdings and more

By | Consumer, Daily Briefs

In today’s briefing:

  • JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades
  • Last Week in Event SPACE: Seven & I, ENN Energy, Sun Corp, Great Eastern Holdings
  • Macy’s Inc. A Tale Of Reimagined Store Initiatives & Digital Integration To Push For Growth!
  • Wall Street Smells A Buyout: Signet Jewelers Just Got a $4.2 Billion Wake-Up Call!
  • Target Corporation Paving The Way Forward With Digital Future With AI
  • Abercrombie & Fitch Quietly Built A Retail Empire — And Just Fired Its Biggest Growth Cannon Yet!
  • Aiming for REITs with Lower Downside Risk and Expectations of Higher Shareholder Returns?
  • Arcos Dorados: Will This Digital Surge Help Gain Market Share In The Latam QSR Market?


JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades

By Gaudenz Schneider

  • This Insight analyses JD.com (9618 HK) option strategies traded over the last five trading days on the Hong Kong Exchange. Strategy highlights and volatility context are provided.
  • Bearish strategies dominate trading activity, outnumbering bullish ones by more than 3:1, with long volatility structures and calendar/diagonal spreads being prevalent.
  • Long tail events: Several strategies follow a pattern of minimal upfront cost (0.1% premium), targeting a significant payout in case of large price movements within a short timeframe. 

Last Week in Event SPACE: Seven & I, ENN Energy, Sun Corp, Great Eastern Holdings

By David Blennerhassett

  • If you don’t think Seven & I (3382 JP)‘s Standalone Plan has legs to go north of here, or ACT gets its act together,  then you should sell into strength.
  • ENN Energy (2688 HK)‘s cash and scrip (into a unlisted H-share-equivalent entity) Offer was not what the doctor ordered.
  • Sun Corp (6736 JP) is cheap to its holding in Cellebrite DI (CLBT US). How cheap depends on the form and structure of its eventual exit.

Macy’s Inc. A Tale Of Reimagined Store Initiatives & Digital Integration To Push For Growth!

By Baptista Research

  • Macy’s Inc.’s fourth quarter 2024 results reflect a mixture of strategic advancements and continued challenges within a shifting retail landscape.
  • First, the positive aspect of Macy’s strategy comes through its “Bold New Chapter” framework, which focuses on enhancing customer experiences, optimizing store operations, and improving merchandising and digital capabilities.
  • This plan is seemingly paying off as Macy’s achieved a 0.2% year-over-year increase in comparable sales, marking its best performance in 11 quarters.

Wall Street Smells A Buyout: Signet Jewelers Just Got a $4.2 Billion Wake-Up Call!

By Baptista Research

  • Signet Jewelers Ltd. is currently navigating a complex landscape, balancing strategic restructuring with the need to address short-term operational challenges.
  • The fourth quarter of the fiscal year reflected a decline in revenue by 6%, yet adjusted earnings per share (EPS) maintained near previous levels due to significant share repurchases.
  • Same-store sales fell by 1.1%, influenced by the absence of a 53rd week from the prior fiscal year, which accounted for an approximate 4-point difference in total sales.

Target Corporation Paving The Way Forward With Digital Future With AI

By Baptista Research

  • Target Corporation’s recent financial presentation unveiled a comprehensive roadmap for potential growth, positioned against the backdrop of a mixed retail environment characterized by both challenges and opportunities.
  • Target emphasized its differentiated retail strategy, focusing on delivering on-trend, affordable products, aiming to capitalize on its unique brand position in the market often affectionately referred to as “Tarzhay” by its consumers.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Abercrombie & Fitch Quietly Built A Retail Empire — And Just Fired Its Biggest Growth Cannon Yet!

By Baptista Research

  • Abercrombie & Fitch Company delivered strong financial performance in the fourth quarter of fiscal year 2024, marking a successful turnaround and growth trajectory driven by robust sales, improved operating efficiencies, and strategic investments.
  • The period ended with notable financial achievements including a 9% increase in net sales year-over-year, translating to $1.58 billion.
  • Excluding the impact of the 53rd week in 2023, the net sales growth was an even more impressive 14%.

Aiming for REITs with Lower Downside Risk and Expectations of Higher Shareholder Returns?

By Aki Matsumoto

  • REITs, whose main players are regional banks that invest as a bond alternative, tend to stop their market decline when the spread with JGB yields approaches 400 basis points.
  • While there is certainly room for REITs to strengthen shareholder returns, the possibility that domestic investors may want stable dividends cannot be denied.
  • Other activist investors are watching with interest to see if the shareholder activism approach works in REITs as well, but the main battleground is still listed equities.

Arcos Dorados: Will This Digital Surge Help Gain Market Share In The Latam QSR Market?

By Baptista Research

  • Arcos Dorados Holdings Inc. reported its fourth quarter and full year 2024 earnings, highlighting both strengths and challenges the company faced over the period.
  • Arcos Dorados, the largest independent McDonald’s franchisee in Latin America and the Caribbean, showcased resilience in a volatile economic landscape, demonstrating growth across sales channels and operational improvements.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: Sinarmas Land and more

By | Daily Briefs, Financials

In today’s briefing:

  • The Widjaja Family’s Tilt For Sinarmas Land: This Needs A Bump


The Widjaja Family’s Tilt For Sinarmas Land: This Needs A Bump

By David Blennerhassett

  • The family trust of the Widjaja Family has made a voluntary unconditional general Offer for the 29.7% in Sinarmas Land (SML SP) not held.
  • The S$0.31 cash Offer (not declared final) for the (mainly) Indo property play is a 12.9% premium to last close; but a 73.9% discount to Sinarmas’ 1H24 NAV of S$1.19/share.
  • The Offer is unconditional in all respects. Trading a spread through terms. This deserves a bump.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Sinarmas Land and more

By | Daily Briefs, Singapore

In today’s briefing:

  • The Widjaja Family’s Tilt For Sinarmas Land: This Needs A Bump


The Widjaja Family’s Tilt For Sinarmas Land: This Needs A Bump

By David Blennerhassett

  • The family trust of the Widjaja Family has made a voluntary unconditional general Offer for the 29.7% in Sinarmas Land (SML SP) not held.
  • The S$0.31 cash Offer (not declared final) for the (mainly) Indo property play is a 12.9% premium to last close; but a 73.9% discount to Sinarmas’ 1H24 NAV of S$1.19/share.
  • The Offer is unconditional in all respects. Trading a spread through terms. This deserves a bump.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Abercrombie & Fitch Co Cl A, Celanese Corp Series A, Cheniere Energy, Cogent Communications Holdings, Dentsply International, Gitlab , HashiCorp , Lumentum Holdings, Macy’s Inc, Signet Jewelers and more

By | Daily Briefs, United States

In today’s briefing:

  • Abercrombie & Fitch Quietly Built A Retail Empire — And Just Fired Its Biggest Growth Cannon Yet!
  • Celanese’s Strategic Shake-Up: New Board, New Markets, New Era of Dominance?
  • Cheniere Energy’s Geopolitical Tailwinds Are Fading—Is The Growth Story Losing Steam?
  • Can Cogent’s IPv4 Strategy Unlock a Massive New Revenue Stream?
  • Dentsply Sirona’s Plan: Merging Tech
  • GitLab’s MASSIVE Jump In SaaS Revenue – Could It Be The Secret Weapon For Future Growth?
  • HashiCorp Ramps Up Cloud Revenue: Could This Be Their Most Profitable Move Yet?
  • Lumentum Holdings: Their Recent Capacity Expansion and Technology Growth Is Fuelling Our Optimism!
  • Macy’s Inc. A Tale Of Reimagined Store Initiatives & Digital Integration To Push For Growth!
  • Wall Street Smells A Buyout: Signet Jewelers Just Got a $4.2 Billion Wake-Up Call!


Abercrombie & Fitch Quietly Built A Retail Empire — And Just Fired Its Biggest Growth Cannon Yet!

By Baptista Research

  • Abercrombie & Fitch Company delivered strong financial performance in the fourth quarter of fiscal year 2024, marking a successful turnaround and growth trajectory driven by robust sales, improved operating efficiencies, and strategic investments.
  • The period ended with notable financial achievements including a 9% increase in net sales year-over-year, translating to $1.58 billion.
  • Excluding the impact of the 53rd week in 2023, the net sales growth was an even more impressive 14%.

Celanese’s Strategic Shake-Up: New Board, New Markets, New Era of Dominance?

By Baptista Research

  • Celanese Corporation recently concluded its Q4 2024 earnings call, led by CEO Scott Richardson and CFO Chuck Kyrish.
  • The company has been taking proactive measures to enhance performance amidst industry challenges.
  • The leadership’s focus has been on cash generation, cost reduction, and strategic divestitures, as reflected in the company’s actions over the past quarters.

Cheniere Energy’s Geopolitical Tailwinds Are Fading—Is The Growth Story Losing Steam?

By Baptista Research

  • Cheniere Energy posted robust results for the fourth quarter and full year 2024, demonstrating its strong operational and financial performance.
  • The company reported a consolidated adjusted EBITDA of approximately $1.6 billion for the fourth quarter, with a full-year total of $6.155 billion.
  • This reflects solid underlying business performance, driven by Cheniere’s focus on safety, operational excellence, customer engagement, and financial discipline.

Can Cogent’s IPv4 Strategy Unlock a Massive New Revenue Stream?

By Baptista Research

  • Cogent Communications Holdings reported its fourth-quarter and full-year 2024 financial results, with some noteworthy developments across its business segments and operations.
  • The company closed the year with total revenue of $252.3 million for the quarter, bringing the full year’s revenue to $1 billion, an increase from $940.9 million in 2023.
  • EBITDA, as adjusted, was $66.9 million for the quarter and $348.4 million for the year, showing a slight decrease compared to the previous year’s $352.5 million.

Dentsply Sirona’s Plan: Merging Tech

By Baptista Research

  • DENTSPLY SIRONA’s fourth-quarter and full-year 2024 earnings report reflects a mixed performance amid ongoing challenges and strategic repositioning.
  • On the positive side, the company experienced growth in several areas, including a 13% uplift in imaging and a 7% increase in Wellspect sales.
  • In Europe, DENTSPLY SIRONA achieved a 2% organic sales growth, supported by significant momentum in Germany and a 20% year-on-year growth in the SureSmile business.

GitLab’s MASSIVE Jump In SaaS Revenue – Could It Be The Secret Weapon For Future Growth?

By Baptista Research

  • GitLab Inc. delivered a strong performance in the fourth quarter of fiscal year 2025, showcasing impressive top line growth and improved profitability metrics.
  • The company’s revenue increased by 29% year-over-year to $211.4 million, driven by robust momentum in its enterprise offerings, particularly GitLab’s Ultimate and Duo products.
  • Notably, the company demonstrated significant operating leverage with a non-GAAP operating margin of 17.7%, an increase of more than 960 basis points compared to the same period in the previous year.

HashiCorp Ramps Up Cloud Revenue: Could This Be Their Most Profitable Move Yet?

By Baptista Research

  • HashiCorp has reported its fiscal 2024 fourth-quarter earnings, surpassing expectations with $156 million in revenue, signaling a 15% year-over-year growth.
  • The company has shown strong overall performance in the context of a challenging economic landscape, indicating potential recovery signs in the market.
  • The non-GAAP remaining performance obligations also reported a growth of 21% year-over-year, reaching $483 million, reflecting continuous demand for its offerings.

Lumentum Holdings: Their Recent Capacity Expansion and Technology Growth Is Fuelling Our Optimism!

By Baptista Research

  • Lumentum Holdings recently released its second-quarter fiscal year 2025 earnings, presenting a blend of strong performance in certain segments and ongoing challenges in others.
  • Led by CEO Alan Lowe, who has announced his retirement, the company highlighted key financial results and strategic initiatives amidst a backdrop of leadership transition.
  • In the second quarter, Lumentum exceeded the high end of its guidance range for both revenue and earnings per share.

Macy’s Inc. A Tale Of Reimagined Store Initiatives & Digital Integration To Push For Growth!

By Baptista Research

  • Macy’s Inc.’s fourth quarter 2024 results reflect a mixture of strategic advancements and continued challenges within a shifting retail landscape.
  • First, the positive aspect of Macy’s strategy comes through its “Bold New Chapter” framework, which focuses on enhancing customer experiences, optimizing store operations, and improving merchandising and digital capabilities.
  • This plan is seemingly paying off as Macy’s achieved a 0.2% year-over-year increase in comparable sales, marking its best performance in 11 quarters.

Wall Street Smells A Buyout: Signet Jewelers Just Got a $4.2 Billion Wake-Up Call!

By Baptista Research

  • Signet Jewelers Ltd. is currently navigating a complex landscape, balancing strategic restructuring with the need to address short-term operational challenges.
  • The fourth quarter of the fiscal year reflected a decline in revenue by 6%, yet adjusted earnings per share (EPS) maintained near previous levels due to significant share repurchases.
  • Same-store sales fell by 1.1%, influenced by the absence of a 53rd week from the prior fiscal year, which accounted for an approximate 4-point difference in total sales.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Prodia and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Prodia (PRDA IJ) – Expanding and Digitally Remastered


Prodia (PRDA IJ) – Expanding and Digitally Remastered

By Angus Mackintosh

  • Prodia (PRDA IJ) FY2024 results reflect an impending recovery, with the company aggressively expanding its outlets by adding 73 over the year, and mostly lower cost points of collection. 
  • The company continues to roll out new tests, with more emphasis on esoteric testing, but also looking at routine testing. It will continue opening new outlets in 2025. 
  • Prodia also continues to expand its digital capabilities through U by Prodia for patients and Prodia for Doctors, and Prodialink. Valuations look attractive with Prodia trading on a low-single-digit EV/EBITDA,

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: JD.com , Hang Seng TECH Index, Innovent Biologics Inc and more

By | China, Daily Briefs

In today’s briefing:

  • JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades
  • ETF Flows in Q1: Inflows for Taiwan, Outflows for China
  • Innovent Biologics Inc (1801 HK): 2024 Product Sales Jump 44% and Loss Narrows; Momentum to Continue


JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades

By Gaudenz Schneider

  • This Insight analyses JD.com (9618 HK) option strategies traded over the last five trading days on the Hong Kong Exchange. Strategy highlights and volatility context are provided.
  • Bearish strategies dominate trading activity, outnumbering bullish ones by more than 3:1, with long volatility structures and calendar/diagonal spreads being prevalent.
  • Long tail events: Several strategies follow a pattern of minimal upfront cost (0.1% premium), targeting a significant payout in case of large price movements within a short timeframe. 

ETF Flows in Q1: Inflows for Taiwan, Outflows for China

By Brian Freitas

  • The largest ETF inflows in the region have been in Taiwan as investors rush into indices that have higher dividend yields.
  • China had large inflows last year as markets floundered. With markets trading in a range over the last 6 months, those flows have reversed in Q1 this year.
  • Australia has seen net inflows this year, while there have been net outflows from Hong Kong, India and Japan focused ETFs.

Innovent Biologics Inc (1801 HK): 2024 Product Sales Jump 44% and Loss Narrows; Momentum to Continue

By Tina Banerjee

  • Innovent Biologics Inc (1801 HK) has announced 2024 result, with total revenue increasing a whopping 52% YoY to RMB9,422M and net loss narrowing 91% YoY to RMB933M.
  • On adjusted basis, the company reported maiden net profit of RMB332M compared with loss of RMB515M in 2023. Innovent is expected to become profitable on reported basis this year.
  • Innovent aims to achieve RMB 20B product revenue in 2027, implying a CAGR of 34% and advance five pipeline assets to the global/multi-regional Phase 3 clinical trial stage by 2030. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Topcon Corp, Shinko Electric Industries, Seven & I Holdings, Kawasaki Heavy Industries, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Topcon (7732 JP): KKR/JICC-Sponsored Preconditional MBO, with Caveats
  • (Mostly) Asia-Pac M&A: Gold Fields, Sinarmas Land, Shinko Electric, Domain, Japfa, Tsuruha/Welcia
  • Last Week in Event SPACE: Seven & I, ENN Energy, Sun Corp, Great Eastern Holdings
  • Quiddity JPX-Nikkei 400 Rebal 2025: End-Mar 2025 Ranks
  • Aiming for REITs with Lower Downside Risk and Expectations of Higher Shareholder Returns?


Topcon (7732 JP): KKR/JICC-Sponsored Preconditional MBO, with Caveats

By Arun George

  • Topcon Corp (7732 JP) recommended a KKR/JICC-sponsored preconditional MBO at JPY3,300, representing an 87.9% premium to the undisturbed price and a 5.4% premium to the last close.
  • The offer is preconditional on regulatory approvals and is scheduled to start at the end of July. The offer is attractive and represents an all-time high. 
  • The offer comes with caveats: the Board recommendation is not unanimous, the lower limit is set below the two-thirds threshold, and KKR offered a higher price during the discussions. 


Last Week in Event SPACE: Seven & I, ENN Energy, Sun Corp, Great Eastern Holdings

By David Blennerhassett

  • If you don’t think Seven & I (3382 JP)‘s Standalone Plan has legs to go north of here, or ACT gets its act together,  then you should sell into strength.
  • ENN Energy (2688 HK)‘s cash and scrip (into a unlisted H-share-equivalent entity) Offer was not what the doctor ordered.
  • Sun Corp (6736 JP) is cheap to its holding in Cellebrite DI (CLBT US). How cheap depends on the form and structure of its eventual exit.

Quiddity JPX-Nikkei 400 Rebal 2025: End-Mar 2025 Ranks

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted capped index composed of 400 constituents.
  • The annual index review takes place in August every year. We look at the latest rankings of potential ADDs/DELs every month.
  • Below is a look at the rankings of potential ADDs/DELs for the JPX-Nikkei 400 August 2025 rebalance based on trading data as of end-March 2025.

Aiming for REITs with Lower Downside Risk and Expectations of Higher Shareholder Returns?

By Aki Matsumoto

  • REITs, whose main players are regional banks that invest as a bond alternative, tend to stop their market decline when the spread with JGB yields approaches 400 basis points.
  • While there is certainly room for REITs to strengthen shareholder returns, the possibility that domestic investors may want stable dividends cannot be denied.
  • Other activist investors are watching with interest to see if the shareholder activism approach works in REITs as well, but the main battleground is still listed equities.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: NetEase , Xiaomi Corp, ENN Energy, BayCurrent Consulting , Hygeia Healthcare Group, Prodia, Orion Holdings, JD.com , Ashok Leyland, Hang Seng TECH Index and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Hang Seng Indexes: FAF Methodology Change for Secondary Listings; Over US$1bn to Buy in NetEase
  • Xiaomi (1810 HK)’s US$5bn Placement: Unfavourable Index Dynamics but Strong Momentum
  • ENN Energy (2688 HK) Privatization: Details & Index Implications
  • Nikkei 225 Index Rebalance: Positioning With a Few Days to Implementation
  • Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome
  • Prodia (PRDA IJ) – Expanding and Digitally Remastered
  • Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)
  • JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades
  • Ashok Leyland Restructuring: Switch UK Winds Down & Switch India’s Strategic Pivot
  • ETF Flows in Q1: Inflows for Taiwan, Outflows for China


Hang Seng Indexes: FAF Methodology Change for Secondary Listings; Over US$1bn to Buy in NetEase

By Brian Freitas


Xiaomi (1810 HK)’s US$5bn Placement: Unfavourable Index Dynamics but Strong Momentum

By Brian Freitas

  • Xiaomi Corp (1810 HK) is looking to place 750m shares at a price range of HK$52.8-54.6/share, a 4.2-7.4% discount from last. That could raise up to HK$40.95bn (US$5.27bn).
  • There will be limited passive buying near-term. There will be more passive buying at the end of May. Then there will be passive selling early June.
  • Shorts will be hurting from the relentless move higher in the stock and there could be short covering if the stock moves lower from these levels.

ENN Energy (2688 HK) Privatization: Details & Index Implications

By Brian Freitas


Nikkei 225 Index Rebalance: Positioning With a Few Days to Implementation

By Brian Freitas


Hygeia Healthcare Group (6078 HK): Slower Revenue Growth and Margin Deterioration Are Worrisome

By Tina Banerjee

  • Hygeia Healthcare Group (6078 HK) reported revenue growth of 9% YoY to RMB4,446 million, mainly driven by a 11% YoY growth in hospital business.
  • Hygeia’s gross profit margin contracted 170bps YoY to 29.9%. Net profit decreased 13% on higher finance cost despite of income tax expenses being lower.
  • Accelerated organic growth and strengthening of margins are crucial to boost valuation.

Prodia (PRDA IJ) – Expanding and Digitally Remastered

By Angus Mackintosh

  • Prodia (PRDA IJ) FY2024 results reflect an impending recovery, with the company aggressively expanding its outlets by adding 73 over the year, and mostly lower cost points of collection. 
  • The company continues to roll out new tests, with more emphasis on esoteric testing, but also looking at routine testing. It will continue opening new outlets in 2025. 
  • Prodia also continues to expand its digital capabilities through U by Prodia for patients and Prodia for Doctors, and Prodialink. Valuations look attractive with Prodia trading on a low-single-digit EV/EBITDA,

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (Starting 31 March 2025)

By Douglas Kim

  • In this insight, we provide the top 10 stocks picks and key catalysts in the Korean stock market for the two weeks starting 31 March.
  • The top 10 picks in this bi-weekly include Orion Holdings, Hyundai Wia, KEPCO KPS, Samsung Electronics, KT, Emart, CJ Logistics, APR, Doosan Enerbility, and HD Hyundai Marine Solution.
  • The biggest near-term negative catalyst on the Korean stock market remains tariffs. The final legal outcome on President Yoon Seok-Yeol is expected to be made by the end of April.

JD.com (9618 HK): Strategic Highlights and Market View from HKEX Top Trades

By Gaudenz Schneider

  • This Insight analyses JD.com (9618 HK) option strategies traded over the last five trading days on the Hong Kong Exchange. Strategy highlights and volatility context are provided.
  • Bearish strategies dominate trading activity, outnumbering bullish ones by more than 3:1, with long volatility structures and calendar/diagonal spreads being prevalent.
  • Long tail events: Several strategies follow a pattern of minimal upfront cost (0.1% premium), targeting a significant payout in case of large price movements within a short timeframe. 

Ashok Leyland Restructuring: Switch UK Winds Down & Switch India’s Strategic Pivot

By Nimish Maheshwari

  • Ashok Leyland (AL IN) plans to shut manufacturing at its UK EV subsidiary, Switch Mobility UK, and shift focus to India and UAE plants.
  • The UK exit curbs cash burn and earnings drag, while Switch India, driven by rising demand, nears breakeven with 1800+ e-Bus orders and 80%+ e-LCV share.
  • This marks a value-accretive pivot, realigning capital to India’s high-growth EV market and improving group-level profitability and return metrics.

ETF Flows in Q1: Inflows for Taiwan, Outflows for China

By Brian Freitas

  • The largest ETF inflows in the region have been in Taiwan as investors rush into indices that have higher dividend yields.
  • China had large inflows last year as markets floundered. With markets trading in a range over the last 6 months, those flows have reversed in Q1 this year.
  • Australia has seen net inflows this year, while there have been net outflows from Hong Kong, India and Japan focused ETFs.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Silicon Box. A Sad Development & Sadly and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Silicon Box. A Sad Development & Sadly, Still A Black Box
  • India’s Capital Markets in Early 2025: Retail Activity Cools Amid Shifting Currents
  • India’s Rice Policy Reversal: Opportunity for Exporters
  • #128 India Insight: Textile $100B Exports by 2030, Wind Energy Hits 48.5 GW, Data Centers Reach $10B
  • #129 India Insight: GOI’s 23k Cr PLI for EMS, NSE 2 Yrs IPO Delay?, Indian Defence Soars
  • Japan Strategy Weekly | Trump’s Surprise 25% Auto Tariff
  • AUCTUS ON FRIDAY – 28/03/2025


Silicon Box. A Sad Development & Sadly, Still A Black Box

By William Keating

  • On September 18 2024, one of the three co-founders of Silicon Box, Dr. Sutardja, sadly passed away. An industry visionary, much loved by many. May he rest in peace.
  • The company’s website still does not reflect this fact, and an interview with their Head of Business just two weeks after his passing, bizarrely doesn’t mention it at all
  • With just six press releases in four years, the company is slow to communicate progress and remains vague on precisely which specific technologies they offer. Still a black box IMO

India’s Capital Markets in Early 2025: Retail Activity Cools Amid Shifting Currents

By Nimish Maheshwari

  • Retail investor activity and demat additions slowed sharply in early 2025, with new account openings falling to a multi-year low of 2.3Mn in February.
  • This signals a broader sentiment reset after a 5-month market correction and FPI outflows, impacting brokers, depositories like CDSL, and exchange volumes.
  • The euphoria phase is cooling, but the long-term equity culture remains intact. Investors should expect near-term consolidation, with stronger players gaining share.

India’s Rice Policy Reversal: Opportunity for Exporters

By Nimish Maheshwari

  • India has lifted major rice export restrictions, ending duties and price caps, triggering a sharp global price correction in rice markets.
  • Global rice prices have dropped 40% since January 2024, providing relief to importing countries and reopening volumes for Indian exporters like  Chaman Lal Setia Exports (CMLTX IN).
  • Expect stronger earnings momentum for Indian rice exporters in FY26 as volumes rebound, margins expand, and India reasserts global dominance.

#128 India Insight: Textile $100B Exports by 2030, Wind Energy Hits 48.5 GW, Data Centers Reach $10B

By Sudarshan Bhandari

  • The textile industry targets $100 billion exports by 2030, seeking policy support for growth and cost competitiveness.
  • India’s wind energy capacity reaches 48.5 GW, with 2,702 MW added in FY25, signaling steady growth and new opportunities.
  • India’s data centre industry grows to $10 billion, driven by rising internet penetration and AI demand, with Mumbai and Chennai leading.

#129 India Insight: GOI’s 23k Cr PLI for EMS, NSE 2 Yrs IPO Delay?, Indian Defence Soars

By Sudarshan Bhandari

  • The cabinet approved a Rs. 22,919 cr PLI for non-semiconductor electronics to boost domestic manufacturing, aiming for significant investment and job creation.
  • National Stock Exchange (NSEIN IN)‘s IPO, initially filed in 2016, faces a potential two-year delay due to regulatory concerns flagged by SEBI, despite recent improvements in share transfer efficiency.
  • India’s defence manufacturing achieved Rs. 1.27 lakh crore output in FY24 and aims for Rs. 3 lakh crore by 2029 through indigenous development and policy reforms.

Japan Strategy Weekly | Trump’s Surprise 25% Auto Tariff

By Mark Chadwick

  • Tokyo stocks faced a volatile week, with the Nikkei falling 1.5% and the Topix down 1.7%, largely impacted by shifting global sentiment and policy uncertainty.
  • Trump’s surprise 25% auto tariff announcement triggered a sharp selloff in automakers, especially Nissan (-7%) and Mazda (-6%).
  • Oracle Japan stock rose 12% on record Q3 earnings, strong cloud growth, and AI projects, while Sumitomo Realty gained 10% on Elliott’s stake and governance reform hopes.

AUCTUS ON FRIDAY – 28/03/2025

By Auctus Advisors

  • Condor Energies (CDR CN) C ; Target price of C$5.60 per share: Production rises again.
  • Maiden reserves report. First LNG sales in Kazakhstan on track for 1H26 – YE24 2P reserves in Uzbekistan were estimated at 18.5 mmboe.
  • 4Q24 production was 10,511 boe/d increasing to 12,019 boe/d in March to date and 12,288 boe/d over the past five days. I

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Bukwang Pharm Announces A Capital Raise of 100 Billion Won and more

By | Daily Briefs, ECM

In today’s briefing:

  • Bukwang Pharm Announces A Capital Raise of 100 Billion Won
  • CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session
  • SmartStop Self Storage (SMA): CEO Confident in Bottoming Self-Storage Market Ahead of IPO


Bukwang Pharm Announces A Capital Raise of 100 Billion Won

By Douglas Kim

  • On 28 March, Bukwang Pharmaceutical (003000 KS) announced a capital raise of 100 billion won. Its share price fell by 13.3% today. 
  • The company plans to issue 30.2 million new shares (44% of outstanding shares). Expected rights offering price is 3,310 won (15.1% lower than current price). 
  • We are negative on Bukwang Pharm mainly due to excessive shareholding dilution from this rights offering as well as lack of valuation merits. 

CoreWeave Inc (CRWV): IPO Opens Below Issue, Closes Flat in Debut Session

By IPO Boutique

  • CoreWeave priced a down-sized transaction of 37.5mm shares at $40.00 ($7 Below the Original $47-$55 range) and opened at $39.00 for a loss of 2.5% at first trade
  • According to our underwriter sources, the deal finished multiple-times oversubscribed with the top three accounts getting 50% of the deal and the top 15 accounts taking down 90% of the transaction.
  • This IPO in particular was a difficult deal to value for IPO investors based upon being a “first mover” in the AI space.

SmartStop Self Storage (SMA): CEO Confident in Bottoming Self-Storage Market Ahead of IPO

By IPO Boutique

  • The company is primarily a “growth by acquisition” story but does have a bullish outlook based upon strong occupancy and improving metrics.
  • The underwriters have reserved up to 10% of the shares in this offering through a directed share program.
  • This IPO “may” be more attractive for investors that “covet yield” versus traditional IPO players.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars